Form 4: Femasys Executive Buys Shares
Insider Transaction (Form 4)
Jeffrey Gerald Mifek, Chief Clinical-Medical Affairs of Femasys Inc, purchased 3,125 shares of common stock on August 7, 2026 for $3.20 per share.
Summary
- Open-market purchase: acquired 3,125 Common Stock at $3.20 ($10,000) on August 7, 2026; holds 3,125 after (Direct).
- Grant/award: acquired 3,125 Common Stock Purchase Warrant on August 7, 2026; holds 3,125 after (Direct).
- Grant/award: acquired 3,125 Common Stock Purchase Warrant (Milestone) on August 7, 2026; holds 3,125 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $10,000, committing personal capital to the stock.
Insider Transactions
Jeffrey Gerald Mifek — Officer (Chief Clinical-Medical Affairs)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-07 | Open-market purchase | Common Stock | 3,125 | $3 | $10.0K | 3,125 |
| 2026-08-07 | Grant/award | Common Stock Purchase Warrant | 3,125 | — | — | 3,125 |
| 2026-08-07 | Grant/award | Common Stock Purchase Warrant (Milestone) | 3,125 | — | — | 3,125 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Open-market purchase (3,125 shares) |
| 2026-08-07 | Grant/award (3,125 shares) |
| 2026-08-07 | Grant/award (3,125 shares) |
Keywords
insider transaction, Form 4, FEMY, FEMASYS INC, bullish, Jeffrey Gerald Mifek
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.